influencer on glp 1 shares GLP-1 journey TikTok Woman Took GLP-1 for 2
Description
Understanding atherosclerosis as a chronic inflammatory disease offers new opportunities for the prevention and treatment of CAD
The groundbreaking 2021 clinical trial of semaglutide still found that almost 14% of participants failed to even lose 5% of their body weight, even after taking the drug for more than one year
doi: 10.1111/dom.13129
Marzorati, M., et al
This, in turn, is leading to a rise in their adoption rates
:max_bytes(150000):strip_icc():focal(749x0:751x2)/carly-weinstein-1-042926-c183da2dd6de47109c85f6db812c0404.jpg)
